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Abstract: Introduction: Blunt cerebrovascular injury (BCVI) is found in 1-2.7% of all blunt trauma when appropriate 
screening criteria are employed. A significant number of patients with BCVI have a latent, or asymptomatic period, in 
which therapeutic intervention based on the appropriate use of angiographic imaging may decrease the risk of an ischemic 
stroke. Methods: Case report and review of literature. Results: A 42 year old woman suffered a fall off a motorcycle and 
was neurologically intact in the emergency room. Fractures involving the transverse foramen of cervical vertebrae were 
found on non-contrast Computed Tomography (CT) but screening for BCVI with angiographic imaging not performed. 
She subsequently suffered an ischemic stroke resulting in significant disability. Published studies that address the use of 
screening criteria for BCVI and subsequent management are reviewed. Conclusion: BCVI results in significant morbidity 
and mortality attributable to ischemic stroke. There is often a latent period between BCVI and occurrence of ischemic 
stroke.  Specific  risk  factors  can  be  used  to  identify  patients  requiring  screening  with  catheter  or  CT  angiography. 
Treatment with antithrombotic agents is the mainstay of treatment of BCVI and may reduce the rate of ischemic stroke. 
Identification  and  treatment  of  asymptomatic  BCVI  in  blunt  trauma  patients  may  prevent  ischemic  stroke  in  a 
predominantly young population. 
Keywords: Cerebrovascular trauma, craniocerebral trauma, spinal injuries, carotid artery diseases, brain ischemia. 
CLINICAL  SCENARIO-  THE  PATIENT  WITH 
BLUNT  TRAUMATIC  INJURY  AND  NO  EARLY 
DEFICIT 
  A 42 year old woman was brought to an outside facility 
after a fall from a motorcycle. She had a 15 minute loss of 
consciousness.  Following  this,  her  Glasgow  Coma  Scale 
(GCS) was 15. CT brain revealed a small amount of trau-
matic subarachnoid hemorrhage. Imaging revealed non-dis-
placed fractures of the transverse processes on the right side 
of the  second, third, fourth and seventh cervical vertebrae 
(C2, C3, C4 and C7) extending into the foramen transver-
sarium (Fig. 1). Imaging also revealed compression fractures 
of sixth and eighth thoracic vertebrae (T6 and T8) without 
impingement on the spinal canal. She was also found to have 
a  fracture  of  the  distal  right  radius,  dislocation  of  the  left 
elbow  and  a  grade  2  splenic  laceration  on  imaging.  She 
underwent closed reduction and external fixation of the right 
forearm. Following the surgery, she was neurologically in-
tact. The next day she abruptly became mute with deviation 
of the head and gaze to the left with right hemiparesis. She 
was emergently transferred to our facility for management of 
acute stroke. A non-contrast CT of the brain revealed loss of 
grey-white  differentiation  in  a  left  middle  cerebral  artery 
distribution and a CT angiogram revealed dissection of both 
carotid  arteries  immediately  proximal  to  the  skull  base  as 
well as dissection of the left vertebral artery in the neck. On 
the  left  side  the  distal  cervical  internal  carotid  artery  was 
found to be nearly occluded (Fig. 2) with only a string sign 
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in  the  carotid  canal,  with  patency  of  the  distal  left  intra-
cranial internal carotid artery and middle cerebral artery. On 
the right side, a raised intimal flap with early signs of pseu-
doaneurysm formation was seen with >50% narrowing of the 
lumen of the vessel (Fig. 3). The left vertebral artery dem-
onstrated luminal narrowing of >50% just prior to entering 
the  foramen  transversarium  of  the  sixth  cervical  vertebra 
(C6) and also demonstrated an intimal flap with narrowing 
of the lumen >25% at the level of the first cervical vertebra 
(C1). Magnetic Resonance Imaging (MRI) of the brain con-
firmed  a  large  left  middle  cerebral  artery  territory  infarct 
(Fig. 4). The patient was not considered to be a candidate for 
anticoagulation with heparin in view of the splenic laceration 
and endovascular management was not performed in view of 
the  completed  infarct  on  the  left  side.  She  was  started  on 
Aspirin 81mg a day. She remained globally aphasic and right 
hemiparetic for the duration of the Intensive Care Unit (ICU) 
stay. The Intracranial Pressure (ICP) via CodmanTM moni-
tor was briefly elevated to 20-30mmHg and the patient was 
successfully  treated  with  osmotherapy  rather  than  decom-
pressive surgery. The patient was transferred out of the ICU 
after several days and seen in clinic follow up 3 months later 
at  which  time  significant  neurological  improvement  was 
seen. The patient was able to communicate and follow com-
mands although a significant  expressive  aphasia remained. 
She was able to ambulate with assistance although she had 
very limited function of her right arm. A repeat CT angio-
gram at 3 months revealed significant healing of the dissec-
tion on the left side to <50% (Fig. 5) while on the right side 
there was progression of the pseudoaneurysm  to 18mm  in 
length (Fig. 6). The left vertebral lesions were unchanged. 
The patient was maintained on 81mg of Aspirin to decrease 
the risk of thromboembolism and referred for endovascular 226     The Open Neuroimaging Journal, 2011, Volume 5  Karamchandani et al. 
management in view of the progressive nature of the pseudo-
aneurysm. 
 
Fig. (1). CT non-contrast of the cervical spine. a). Fracture of the 
right transverse process of C2 involving the transverse foramen. b). 
Similar fracture passing through right transverse foramen of C3. 
 
Fig. (2). CT  angiogram oblique view. Grade 2  injury of the left 
carotid artery with severe narrowing of the lumen proximal to the 
skull base. There was only a trickle of flow visualized in the petrous 
and cavernous segments distal to this lesion. 
 
Fig. (3). CT angiogram oblique view. Grade 2 injury of the right 
carotid artery proximal to the skull base with raised intimal flap. 
 
Fig.  (4).  MRI  of  the  brain  with  region  of  restricted  diffusion 
consistent with infarct  in the  territory of  the left middle  cerebral 
artery. 
 
Fig.  (5).  CT  angiogram  oblique  view,  at  3  month  follow-up. 
Significant healing of the left carotid injury. There was normal flow 
visualized distal to the injury. 
 
Fig.  (6).  CT  angiogram  oblique  view,  at  3  month  follow-up. 
Progression  of  the  injury  in  the  right  carotid  artery  to 
pseudoaneurysm, 18mm in length. Neuroimaging in the Latent Period of Blunt Traumatic Cerebrovascular Injury  The Open Neuroimaging Journal, 2011, Volume 5     227 
Introduction 
  An estimated 1.5 million head injuries occur every year 
in the United States and Traumatic Brain Injury (TBI) is the 
leading cause of death and disability in children and adults 
from ages 1 to 44 [1]. Blunt cerebrovascular injury (BCVI), 
or injury to the carotid and vertebral arteries in the setting of 
blunt trauma, was originally reported to be very uncommon, 
occurring  in  0.08%  of  patients  [2].  More  recent  studies, 
however, report a prevalence ranging from 1.1-1.6% of all 
patients with blunt trauma [3-5], with a prevalence of 2.7% 
in the most severely injured (injury severity score>16) [6]. 
This increased prevalence is almost certainly a consequence 
of screening protocols instituted at several institutions. BCVI 
results  in  significant  disability  and  morbidity-  32-67%  for 
carotid injury and 14-24% for vertebral injury [7-11]. While 
patients  with  BCVI  often  die  because  of  other  injuries 
(particularly  severe  TBI),  there  appears  to  be  significant 
attributable mortality to BCVI itself, with one study report-
ing  attributable  mortality  up  to  38%  [4].  The  more  wide-
spread  use  of  screening  for  BCVI  using  CT  or  catheter 
angiography is mostly driven by the awareness that a signi-
ficant  number  of  these  injuries  are  initially  asymptomatic, 
prior  to  presenting  with  symptoms  of  cerebral  ischemia/ 
infarction,  and  that  detecting  these  lesions  when  they  are 
asymptomatic  may  provide  an  important  window  of 
opportunity to prevent ischemic strokes. 
Mechanisms of Injury 
  The mechanism of blunt injury to the carotid appears to 
be through longitudinal stretch of the vessel, often against 
the transverse processes of C1/ C2 in the context of hyper-
extension and contra-lateral rotation, thereby accounting for 
the  usual  location  of  these  injuries  in  the  distal  cervical 
internal carotid artery, just proximal  to the skull base [12, 
13].  Carotid  BCVI  also  occurs  with  fractures  of  the  skull 
base, particularly those involving the carotid canal. Vertebral 
artery  injuries  occur  in  the  context  of  spinal  subluxation/ 
dislocation  and  fractures  running  through  the  transverse 
foramen  resulting  in  stretching  of  the  otherwise  fixed 
vertebral  artery against  the  surrounding bony structures or 
dural margin [14, 15]. Other mechanisms of BCVI include 
direct trauma to the anterior neck (as with hanging), intra-
oral  injuries  and  displacement/  fracture  of  the  mandible. 
Thromboembolism  likely  results  from  platelet  aggregates 
that form when the intima is disrupted or within pseudoaneu-
rysms,  resulting  in  distal  embolism  or  luminal  narrowing/ 
occlusion and limitation or obstruction of flow. Stroke may 
also  occur  when  intramural  hematomas  and  intimal  flaps 
cause  hemodynamic  compromise.  Available  data  suggests 
that the majority of patients with carotid artery dissections 
suffer brain injury more consistent with a thromboembolic 
mechanism  [16].  Less  common  mechanisms  of  stroke 
include complete transection and venous hypertension with 
arterio-venous fistulas (AVF). 
Screening Criteria for the Use of Neuroimaging 
  It is clear that while some cases of BCVI present early 
with  focal  neurological  signs/  symptoms  or  active  arterial 
bleeding and others never become symptomatic,  there is a 
significant group of patientswith BCVI who demonstrate a 
latent period, lasting from hours to days, before suffering an 
ischemic stroke. In different case series, 23-50% of patients 
with BCVI who develop symptomatic cerebral ischemia do 
so  after  a  period  of  12  or  more  hours  after  the  injury, 
sometimes up to 7 days [17-20]. This latent period may be a 
window in which therapeutic intervention can be initiated to 
prevent  subsequent  cerebral  ischemia.  Knowledge  of  the 
traumatic  injuries that are most commonly associated with 
BCVI, including asymptomatic BCVI, has led some authors 
to  propose  screening  criteria  based  on  certain  clinical  or 
radiological findings. The  most widely used screening cri-
teria for BCVI were developed in Denver, Colorado, based 
on  the  work  of  Biffl  [9,  21]  and  Cothren  [22]  et  al.  The 
Denver  criteria  are  listed  in  Table  1.  In  addition  to  these 
criteria, the presence of major  chest  trauma also  seems  to 
predict the presence of BCVI [23]. It is important to note that 
20-24% of patients with BCVI will not be picked up by the 
aforementioned  screening  criteria  and  may  present  with 
neurological signs and symptoms despite a policy of screen-
ing for BCVI [19, 21]. Interestingly, our patient described 
above, who was not screened for BCVI, did not have any of 
the  classical  risk  factors  for  carotid  injury  (base  of  skull 
fracture, diffuse axonal injury, Le Fort 2 or 3 fracture) but 
did have a risk factor for vertebral artery injury (fractures 
passing through the transverse foramen, Fig. (1)) and there-
fore would have fit screening criteria for BCVI. It is useful 
to note here that multi-vessel injury, as seen in our patient, is 
common,  occurring  in  18-38%  of  BCVI  and  should  be 
actively looked for when any one vessel injury is detected 
[18, 19, 24, 25]. 
Table 1. Denver Screening Criteria for BCVI
18 
 
Signs/symptoms of BCVI 
Arterial hemorrhage from mouth, ears, nose or wound 
Cervical bruit in a patient <50 years old 
Expanding cervical hematoma 
Focal neurological deficit 
Neurologic examination incongruous with CAT scan findings 
Ischemic stroke on secondary CAT scan 
 
Risk factors for BCVI 
High-energy transfer mechanism with 
Lefort II or III fracture 
 Cervical spine subluxation, fractures extending intotransverse foramen, 
fractures of C1–C3 
Basilar skull fracture with carotid canal involvement 
Diffuse axonal injury with Glasgow Coma Scale score _6 
Near hanging with anoxic brain injury 
 
Diagnosis and Grading of Injury  
  The  diagnostic  tool  most  appropriate  for  screening  for 
BCVI is a matter of debate. Four vessel digital subtraction 
angiography (DSA) is widely accepted as the gold standard, 
but  does  involve  the  small  but  definitive  (generally  <1%) 
risk of procedural thromboembolism and stroke, as well as 
minor or major bleeding into the thigh or retroperitoneum. 228     The Open Neuroimaging Journal, 2011, Volume 5  Karamchandani et al. 
More  recently,  multidetector  Computed  Tomographic 
Angiography  (mdCTA)  has  seen  widespread  use  as  a  less 
invasive screening tool for BCVI. The frequent need for CT 
scanning of other parts of the body makes this particularly 
expedient, with some institutions including CT angiography 
of  the  neck  as  part  of  a  whole-  body  rapid  multidetector 
spiral CT scan, involving one spiral data acquisition and one 
contrast  injection  for  the  entire  body  [26].  While  whole- 
body scanning is much more frequently associated with the 
presence  of  artifacts,  it  does  seem  to  detect  clinically 
significant BCVI with accuracy comparable to focused md 
CTA of the neck [24]. Two studies have looked at the use of 
mdCTA as a screening tool for BCVI with DSA performed 
only  to  confirm  positive  findings  on  CTA  [3,  27],  No 
patients with negative mdCTAs (who did not undergo DSA 
and were followed clinically) suffered clinical neurological 
decline in either study. Two studies have directly compared 
16-channel  mdCTA  to  DSA.  The  earlier  study  performed 
both  mdCTA  and  DSA  in  all  patients  who  met  screening 
criteria  for  BCVI  [28].  The  sensitivity  and  specificity  of 
mdCTA  compared  to  DSA  were  98%  and  100%  respect-
ively. A subsequent study that also performed mdCTA and 
DSA in all patients meeting screening criteria reported very 
different results, with sensitivity and specificity of only 74% 
and 84% respectively [29]. Of note, though, when only the 
second  half  of  enrolled  patients  were  analyzed,  the  sensi-
tivity and specificity jumped to 100% and 86%, suggesting 
that  the  presence  of  a  significant  learning  curve  for 
radiologists in the use of mdCTA to diagnose BCVI. 
  Magnetic Resonance Imaging (MRI) and Magnetic Reso-
nance Angiography (MRA) are frequently used in the con-
text of ischemic stroke for the diagnosis of cervical artery 
dissection. A retrospective comparison of 18 patients with 
ischemic  stroke  associated  with  cervical  artery  dissection 
evaluated with both mdCTA and MRI/ MRA suggested that 
CTA  may  be  superior  for  the  depiction  of  dissection, 
particularly in the vertebral artery [30]. MRI and MRA have 
not been systematically evaluated for the diagnosis of BCVI. 
The use of MRImay, at several institutions, pose logistical 
problems in terms of availability, time taken for the study 
and  the  ability  to  monitor  potentially  unstable  trauma 
patients  while  in  the  scanner.  Duplex  ultrasound  has  been 
used  as  a  non-angiographic  method  to  screen  for  BCVI. 
Carotid duplex ultrasound appears to have very poor sensi-
tivity  in  comparison  to  4-vessel  or  CT  angiography.  One 
retrospective study compared 407 trauma patients screened 
with  mdCTA  for  BCVI  with  an  earlier  group  of  1471 
patients  screened  with  carotid  duplex  sonography  [31]. 
Carotid duplex detected five cases of BCVI but missed an-
other eight cases associated with ischemic stroke. Sensitivity 
and specificity of carotid duplex were 38.5% (95% Confi-
dence  Interval  [95%CI]:  13.9-68.4%)  and  100%  (95%CI, 
99.7-100%), respectively. In contrast, CT angiography detec-
ted BCVI in 11 patients, with a sensitivity of 100% (95%CI 
71.5-100%), but produced one false-positive result. 
  In order to standardize the reporting of BCVI, Biffl and 
coworkers  have  proposed  an  angiography  based  grading 
system for BCVIs (Table 2) [32]. The risk of stroke appears 
to be directly correlated with angiographic grade (Table 2) in 
carotid  BCVI,  while  in  vertebral  BCVI,  interestingly,  the 
highest risk of stroke appears  to be with Grade II injuries 
(luminal narrowing >25%, intraluminal thrombi or AVF) and 
least with Grade III (pseudoaneurysm) [17]. 
Table 2.   Blunt  Carotid  and  Vertebral  Arterial  Injury 
Grading Scale
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Injury 
Grade 
Description 
Prevalence of 
Stroke with Carotid 
Injury
17 
I  Luminal irregularity or dissection 
with _25% luminal narrowing 
3% 
II 
Dissection or intramural hematoma 
with _25% luminalnarrowing, 
intraluminal thrombus, or raised 
intimal flap 
11% 
III  Pseudoaneurysm  33% 
IV  Occlusion  44% 
V  Transection with free extravasation  100% 
 
Treatment 
  Medical treatment with antithrombotic agents appears to 
be the mainstay of management of BCVI. A number of retro-
spective studies have shown a large reduction in the rate of 
neurological sequelae with the use of antithrombotic therapy 
compared to patients who, for any reason, were not treated 
with anticoagulant or antiplatelet therapy [8, 10, 18]. In one 
such study by Cothren et al., BCVI was diagnosed in 244 
patients  using  the  Denver  screening  criteria  [11].  Of  187 
patients eligible for and treated with antithrombotic therapy, 
one  (0.5%)  suffered  a  stroke  while  21%  of  patients  not 
treated  (generally  because  of  the  presence  because  of  a 
contraindication  such  as  bleeding  risk)  suffered  a  stroke. 
Patients  who  suffered  strokes  had  a  significantly  higher 
BCVI-attributable mortality (21% in carotid BCVI, 18% in 
vertebral  BCVI)  compared  to  those  who  did  not  suffer  a 
stroke (0% for both carotid and vertebral BCVI). In another 
study  by  the  same  group,  over  a  7  year  period  in  which 
prospective  screening  criteria  for  angiography  were  used, 
643 patients were screened and 114 patients found to have 
blunt  carotid  injury.  Of  these,  73  were  treated  with  either 
anticoagulation (n=56) or antithrombotic agents (n=17) and 
the  rest  were  not  treated,  most  commonly  because  of  the 
presence of contraindications. None of the treated patients 
developed  an  ischemic  stroke  while  46%  of  the  untreated 
patients  suffered  “ischemic  neurologic  events”  [18].  There 
are  no  randomized  controlled  trials  comparing  anticoagu-
lation with Heparin to the use of antiplatelet agents in BCVI. 
The large number of patients who would likely need to be 
enrolled  to  obtain  a  meaningful  result  makes  such  a  trial 
challenging.  Most  studies  that  have  performed  subgroup 
analysis  of  non-randomized  and  retrospective  studies  to 
address this question have found no difference between the 
two groups [5, 18, 33]. In the absence of data from rando-
mized controlled trials, some experts, including the Denver 
group, do preferentially recommend  the use of Heparin  in 
patients without major bleeding risk on the basis of some 
studies that have demonstrated a trend toward reduction in 
stroke rates with Heparin as compared to Aspirin. One study 
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with  Heparin  vs.  Aspirin  [34].  Serious  bleeding  complica-
tions can, however, complicate the use of anticoagulation. In 
the  same  study  from  the  Denver  group  by  Biffl  et  al., 
bleeding requiring transfusion or cessation of Heparin was 
seen in 54% of patients, on the basis of which the authors 
recommend  a  more  conservative  Partial  Thromboplastin 
Time target of 40-50 seconds while using Heparin. Worsen-
ing of intracranial bleeding has also been reported with the 
use of anticoagulation to treat BCVI [35]. Our patient was 
treated with Aspirin instead of Heparin- despite the presence 
of  a  symptomatic  near-occlusion  of  the  left  carotid  and  a 
Grade 2 injury of the right carotid- because of the presence 
of a concomitant splenic laceration.  
  No data currently exists on when antithrombotic therapy 
should be discontinued. Some authorities recommend mak-
ing a decision based on follow-up imaging after 7-10 days 
[36].  Antithrombotic  therapy  is  stopped  if  the  injury  has 
healed,  while  if  persistent  injury  is  seen,  therapy  with  an 
antiplatelet or Warfarin is continued for another 3 months at 
which time a DSA or mdCTA is repeated. 
  The role of open surgery appears to be very limited in 
BCVI. Most carotid injuries are close to the skull base and 
not easily accessible. In patients with surgically accessible 
injuries,  however,  patients  who  do  not  have  a  dense 
neurological deficit who undergo reperfusion appear to do 
better than those who undergo ligation [37]. Patients with a 
dense  neurological  deficit,  however,  seem  to  do  poorly 
regardless of the specific surgical treatment chosen [38]. 
  The role of endovascular techniques in the management 
of  BCVI  is  not  clearly  defined.  Several  case  series  have 
indicated the safety and feasibility of emoblization of pseu-
doaneurysms  and stenting of intimal  injuries [39-42]. One 
retrospective study from the Denver group, however, repor-
ted a much higher rate of carotid occlusion in patients who 
underwent  stenting  than  those  who  underwent  medical 
management with a consequently higher rate of symptomatic 
complications (21% vs. 5%) [43].  The retrospective nature 
of this study and the likelihood of selection bias  makes it 
difficult  to  draw  meaningful  conclusions  from  this  study, 
however, and other studies have reported very good results 
with  endovascular  procedures  performed  in  patients  with 
dissections.  Advances  in  endovascular  techniques  and 
devices have made stenting and coiling of distal extracranial 
as  well  as  intracranial  lesions  feasible.  Ansari  et  al.  have 
reported excellent results with the use of the neuroform stent 
to treat distal extracranial as well as intracranial dissections 
[44]. Kadkhodayan et al. reported a case series of 26 patients 
with carotid dissections, with or without associated pseudo-
aneurysm, treated with angioplasty and stenting [45]. After 
stenting,  only  one  patient  was  left  with  significant  vessel 
lumen stenosis (50%). Three patients experienced procedural 
TIAs,  and  there  were  no  procedural  strokes.  One  patient 
developed a new intimal flap, resulting in termination of the 
procedure. At mean follow-up of 14.6 months, two patients 
experienced  angiographic  occlusion  of  the  treated  vessel 
(one  at  22  days  and  the  other  at  3.4  months).  One  was 
asymptomatic, while the other experienced a stroke contra-
lateral to the treated side. Two patients experienced recurrent 
ipsilateral Transient Ischemic Attacks, at 2.7 months and 12 
months, respectively. The use of endovascular stents in pa-
tients with multi-system trauma can be problematic because 
of  the  need  for  dual  antiplatelet  therapy,  often  for  several 
months, in patients at high risk for bleeding. 
Follow-Up Imaging 
  BCVIs  are  dynamic  lesions  and  both  treated  and  un-
treated injuries can either heal or progress. Most authorities 
recommend obtaining follow-up imaging after 7-10 days in 
patients  with  BCVI,  since  this  appears  to  frequently  in-
fluence management. As an example, Biffl et al. reported the 
results  of  follow  up  imaging  at  7-10  days  in  114  patients 
with carotid BCVI and 79 patients with vertebral BCVI [5]. 
57% of grade 1 and 8% of grade 2 injuries healed, allowing 
cessation of antithrombotic therapy. 8% of grade 1 and 43% 
of grade 2 lesion demonstrated progression, requiring refer-
ral for endovascular management. Patients with grade 3 and 
4 injuries, however, rarely showed much change, remaining 
stable 93% and 82% of the time. Interestingly, in our patient, 
both healing and progression was seen in different vessels, 
with  the  symptomatic  left  carotid  near-occlusion  demons-
trating  significant  healing;  and  the  right  carotid  BCVI 
demonstrating progression from a grade 2 to a sizeable grade 
3 injury, requiring referral for endovascular management. 
Efficacy of Angiographic Screening 
  No prospective, randomized controlled trial has validated 
a policy of aggressively screening blunt trauma patients for 
BCVI.  Many  non-randomized  studies,  including  the  pre-
viously  mentioned  studies  by  the  Denver  group,  however, 
strongly suggest a large reduction in the risk of stroke when 
asymptomatic  patients  with  BCVI  are  treated  with  anti-
thrombotic  agents [8,10,11,18]. In a  more recent study by 
Schneidereit  et  al.,  8-channel  mdCTA  was  used  to  screen 
patients with prospectively identified risk factors for BCVI 
[4].  170  patients  were  screened  over  a  year  and  the  pre-
valence of BCVI rose from 0.17% to 1.4%, while, more sig-
nificantly,  the  BCVI  related  stroke  rate  as  well  as  BCVI-
specific mortality dropped to 0% from 67%  and 38% res-
pectively. While there may significant expenditure with the 
widespread use of screening for BCVI, the increasing use of 
whole- body mdCTA contrast imaging with a single spiral 
acquisition  and  a  single  contrast  injection  means  that  less 
expenditure  may  be  required  for  dedicated  screening  for 
BCVI. Screening for BCVI may be cost-effective even when 
DSA is used to screen for BCVI. In the study by Cothren  
et al., 187 patients with asymptomatic BCVI were detected, 
preventing 32 strokes in the authors’ estimation. The authors 
concluded  that  at  $6500  per  DSA,  the  expense  per  stroke 
avoided was about $154,000 and that screening with DSA 
was therefore cost-effective [11]. 
The Clinical Scenario 
  A 42 year old woman is admitted with multi-system blunt 
trauma and is neurologically intact. Fractures involving the 
transverse foramina of the cervical vertebrae- a recognized 
radiographic risk factor for blunt cerebrovascular injury- are 
discovered on screening CT of the Cervical Spine, but angio-
graphic screening for BCVI not performed, and antithrom-
botic/ antiplatelet  therapy not initiated. 24 hours following 
admission the patient develops a large ischemic stroke in the 
territory  of  the  left  middle  cerebral  artery.  Subsequent 
angiographic imaging with mdCTA reveals Grade 2 BCVI of 230     The Open Neuroimaging Journal, 2011, Volume 5  Karamchandani et al. 
both  carotid  arteries.  The  patient  demonstrates  significant 
disability at follow up. 
CONCLUSION 
  The use of angiographic  imaging to detect  cerebrovas-
cular  injury  based  on  appropriate  clinical  and  imaging 
screening criteria in patients with blunt  trauma may be an 
under-recognized opportunity to reduce morbidity and long-
term  disability  in  these  patients.  Injuries  when  discovered 
should  be  treated  appropriately  and  follow  up  imaging 
performed to determine the evolution of the injury. 
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